A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
ConditionSurgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age45+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
The purpose of this study is to find out how many participants are interested in a surgical preventive procedure after watching an educational video. Before and after watching the video, participants will complete questionnaires in the clinic.
Eligibility criteria
Qualifiers
Age ≥45 years
Scheduled visit with a nongynecologic surgeon
Female or assigned female at birth
Age ≥45 years
Disqualifiers
Not fluent in English or Spanish
Known inherited ovarian cancer susceptibility
Personal history of a gynecologic malignancy
Carrier of a hereditary breast or ovarian cancer variant (e.g., BRCA1, BRCA2, BRIP1, PALB2, RAD51C, RAD51D, MLH1, MSH2, MSH6, PMS2)
Trial design
Treatments tested in this trial
- Educational Module
- Salpingectomy
Treatment groups
266 Participants
are divided into 1 treatment groupLocations
10Johns Hopkins University (Data Collection Only)21287, BaltimoreMaryland, United States
Dana Farber Cancer Institute (Data Collection Only)02115, BostonMassachusetts, United States
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)07920, Basking RidgeNew Jersey, United States
Memorial Sloan Kettering Monmouth (Limited protocol activities)07748, MiddletownNew Jersey, United States
Sponsors and collaborators
Memorial Sloan Kettering Cancer Center
Lead sponsor
Source ClinicalTrials.gov